Treatment of sciatica due to intervertebral disc herniation with chymoral tablets

G. Gaspardy, G. Bálint, M. Mitusova, G. Lorincz

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Summary: Thirty patients suffering from sciatica have been treated with purified enzyme concentrate tablets and placebo in a double-blind cross-over trial. In those patients who at first received the proteolytic enzymes considerable decrease in symptoms was observed, while the subsequent administration of placebo tablets did not substantially alter the symptoms. In those patients who received first placebo tablets, little decrease in symptoms was shown until they had also received proteolytic enzyme tablets. Comparison of the incidence of symptoms after one week's treatment between the two groups gave statistiscally significant results.

Original languageEnglish
Pages (from-to)14-19
Number of pages6
JournalRheumatology
Volume11
Issue number1
DOIs
Publication statusPublished - Feb 1971

Fingerprint

intervertebral disks
Sciatica
tablets
Intervertebral Disc
Tablets
Enzymes
enzymes
Placebos
Crossover Trial
Decrease
Peptide Hydrolases
Incidence
Therapeutics
Cross-Over Studies
incidence
trypsin drug combination chymotrypsin

ASJC Scopus subject areas

  • Molecular Biology
  • Statistics and Probability
  • Computational Mathematics
  • Condensed Matter Physics
  • Applied Mathematics
  • Pharmacology (medical)
  • Rheumatology
  • Medicine(all)

Cite this

Treatment of sciatica due to intervertebral disc herniation with chymoral tablets. / Gaspardy, G.; Bálint, G.; Mitusova, M.; Lorincz, G.

In: Rheumatology, Vol. 11, No. 1, 02.1971, p. 14-19.

Research output: Contribution to journalArticle

Gaspardy, G. ; Bálint, G. ; Mitusova, M. ; Lorincz, G. / Treatment of sciatica due to intervertebral disc herniation with chymoral tablets. In: Rheumatology. 1971 ; Vol. 11, No. 1. pp. 14-19.
@article{0a3f509cec1842beabde6d2dc83c7883,
title = "Treatment of sciatica due to intervertebral disc herniation with chymoral tablets",
abstract = "Summary: Thirty patients suffering from sciatica have been treated with purified enzyme concentrate tablets and placebo in a double-blind cross-over trial. In those patients who at first received the proteolytic enzymes considerable decrease in symptoms was observed, while the subsequent administration of placebo tablets did not substantially alter the symptoms. In those patients who received first placebo tablets, little decrease in symptoms was shown until they had also received proteolytic enzyme tablets. Comparison of the incidence of symptoms after one week's treatment between the two groups gave statistiscally significant results.",
author = "G. Gaspardy and G. B{\'a}lint and M. Mitusova and G. Lorincz",
year = "1971",
month = "2",
doi = "10.1093/rheumatology/11.1.14",
language = "English",
volume = "11",
pages = "14--19",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Treatment of sciatica due to intervertebral disc herniation with chymoral tablets

AU - Gaspardy, G.

AU - Bálint, G.

AU - Mitusova, M.

AU - Lorincz, G.

PY - 1971/2

Y1 - 1971/2

N2 - Summary: Thirty patients suffering from sciatica have been treated with purified enzyme concentrate tablets and placebo in a double-blind cross-over trial. In those patients who at first received the proteolytic enzymes considerable decrease in symptoms was observed, while the subsequent administration of placebo tablets did not substantially alter the symptoms. In those patients who received first placebo tablets, little decrease in symptoms was shown until they had also received proteolytic enzyme tablets. Comparison of the incidence of symptoms after one week's treatment between the two groups gave statistiscally significant results.

AB - Summary: Thirty patients suffering from sciatica have been treated with purified enzyme concentrate tablets and placebo in a double-blind cross-over trial. In those patients who at first received the proteolytic enzymes considerable decrease in symptoms was observed, while the subsequent administration of placebo tablets did not substantially alter the symptoms. In those patients who received first placebo tablets, little decrease in symptoms was shown until they had also received proteolytic enzyme tablets. Comparison of the incidence of symptoms after one week's treatment between the two groups gave statistiscally significant results.

UR - http://www.scopus.com/inward/record.url?scp=0015012848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015012848&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/11.1.14

DO - 10.1093/rheumatology/11.1.14

M3 - Article

VL - 11

SP - 14

EP - 19

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 1

ER -